Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 174.23 Billion | USD 704.87 Billion | 16.80% | 2023 |
The Global Exosome Research Products Market size accounted for USD 174.23 Billion in 2023 and is expected to reach USD 704.87 Billion by 2032, growing at a CAGR of 16.80% from 2024 to 2032.
The report covers forecast and analysis for the exosome research products market on a global and regional level. The study provides historic data from 2018 along with forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the exosome research products market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the exosome research products market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the exosome research products market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the exosome research products market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the exosome research products market on global and regional basis.
The study provides a decisive view of the exosome research products by segmenting the market based on application, product and service, end-user, and region. All the segments of the exosome research products market have been investigated based on current and forecast demand and trends and the market is forecasted from 2024 to 2032.
Exosomes are secreted by a variety of cells as extracellular vesicles and are found in body fluids such as saliva, plasma, urine, and serum. Exosomes are made up of lipid bilayer membranes and are usually filled with different proteins, and nucleic acids like mRNA, microRNA, and DNA. Exosomes bear specific protein markers such as heat shock proteins, tetraspanins, and EpCam depending on the cellular origin. These exosomes can be used as biomarkers for various chronic diseases including diabetes, cancer, neurological diseases, etc. Exosomes have become of prime importance to researchers for studying biological functions and the development of advanced therapeutics and non-invasive diagnostics.
The exosome research products market is driven by the increasing adoption of exosome-based procedures along with increasing investments in life science research. Increasing cancer prevalence across the globe is another important factor that is boosting the growth of the exosome research products market. However, the dearth of trained professionals and lack of funds in developing regions may hamper the growth of this market. Increasing preference for personalized medicine and growing research applications in exosomes based products are expected to open new opportunities for market players in the exosome research products market.
Based on product and service, the global exosome research products market is bifurcated into instruments, reagents & kits, and services. The reagents & kits segment held the largest market share in 2018 owing to their continuous and increasing use for exosome research projects. An increasing number of exosome-based test offerings by diagnostic laboratories and technological advancements are expected to drive demand for advanced instruments. The services segment is expected to grow at the highest CAGR over the forecast period.
Based on applications market is segmented into cancer and non-cancer applications. The cancer applications segment is further split into Prostate Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, and Other Cancers. The lung cancer application segment held the largest market share in 2018 owing to the increasing prevalence of lung cancer across the globe. The breast cancer segment is expected to grow at the highest CAGR over the forecast period owing to increasing government initiatives and awareness programs.
Hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and academic & research institutes constitute the end-user segment. The academic & research institutes segment held the largest market share in 2018 whereas increasing investments and research activities by major pharmaceutical and biotechnology companies are expected to boost the market growth of pharmaceutical & biotechnology companies' end-user segment over the forecast period.
Report Attributes | Report Details |
---|---|
Report Name | Exosome Research Products Market Research Report |
Market Size in 2023 | USD 174.23 Billion |
Market Forecast in 2032 | USD 704.87 Billion |
Growth Rate | CAGR of 16.80% |
Number of Pages | 255 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | QIAGEN N.V., Thermo Fisher Scientific, Bio-Techne, NX Pharmagen, System Biosciences, LLC., AMS Biotechnology Limited, Miltenyi Biotec, Lonza, NanoSomiX, and Norgen Biotek Corp. |
Segments Covered | By Product & Service, By Application, By End-User, By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Exosome Research Products Market: Regional Landscape
At the regional level, North America held the largest market share of the global exosome research products market in 2023. Increasing private and public investment, increasing cancer burden, presence of developed infrastructure, and government funding are factors that boost the market growth in this region. Europe was the second-largest regional market in 2023.
The growth in Europe for the exosome research products market is supported by increasing investments, favorable grants and funding to academic and research institutes, and increasing healthcare expenditure. Over the forecast period, the Asia Pacific region is projected to register the highest CAGR as a result of the increasing geriatric population base and increasing cancer burden in emerging countries like India, China, etc.
Major players included in the report are
The report segment of global exosome research products market as follows:
Global Exosome Research Products Market: By Product & Service
Global Exosome Research Products Market: By Application
Global Exosome Research Products Market: By End-User
Global Exosome Research Products Market: By Region
FrequentlyAsked Questions
Scientists employ exosome research items to examine and manipulate cell-secreted vesicles. Exosomes transport proteins, nucleic acids, and lipids between cells, enabling intercellular communication. Exosome research products identify, characterize, analyze, and alter exosomes to study their functions in health and disease, develop diagnostic tools, and investigate their drug delivery and therapeutic potential. These goods include exosome isolation kits, analytical tools, labeling reagents, and other technologies for studying these vital biological components.
Global exosome research products market is growth is fueled by various factors such as growing adoption of exosomes based procedures in life science research and increasing investments exosomes research.
According to the report, global demand for exosome research products market was valued at approximately USD 174.23 Billion in 2023, and is expected to generate revenue of around USD 704.87 billion by end of 2032, growing at a CAGR of around 16.80% between 2024 and 2032.
North America dominated the global exosome research products market with largest revenue share in 2018. This growth is attributed to increasing private and public investment, presence of developed infrastructure, increasing cancer burden and favorable government funding in this region.
Major players included in the report are QIAGEN N.V., Thermo Fisher Scientific, Bio-Techne, NX Pharmagen, System Biosciences, LLC., AMS Biotechnology Limited, Miltenyi Biotec, Lonza, NanoSomiX, and Norgen Biotek Corp.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed